Resources

Your selections:

Clear all

Show Filters

We found 236 resources that match your search.

PegIntron is an antiviral indicated for treatment of Chronic Hepatitis C (CHC) in patients with compensated liver disease. (1.1)

Document Date:

Document Date:

Document Date:

Document Date:

Document Date:

PRIFTIN is a rifamycin antimycobacterial drug indicated in patients 12 years of age and older for the treatment of active pulmonary tuberculosis (TB) caused by Mycobacterium tuberculosis in combination with one or more anti-tuberculosis (anti-TB) drugs to which the isolate is susceptible. (1.1) *…

Document Date:

Protocol Development Lifecycle flowchart

Document Date:

Quick reference card for protocol registration at a glance.

Document Date:

Division of AIDS (DAIDS) protocol registration checklist. NOTE: This form is not required if submitting materials through the DAIDS Protocol Registration System (DPRS).

Document Date:

Division of AIDS (DAIDS) protocol registration checklist. NOTE: This form is not required if submitting materials through the DAIDS Protocol Registration System (DPRS).

Document Date:

Use this to make sure you don't miss any required pieces of information when recording and reporting an adverse event.

Document Date:

One-sheet references for writing a narrative case summary of an adverse event and for evaluation and follow-up.

Document Date:

Document Date:

The following side effects have been associated with the use of raltegravir:

Document Date:

Required documentation of risk/benefit category and approval of clinical studies for inclusion of children by institutional review boards/ethics committees based on 45 CFR 46, Subpart D.

Document Date:

Document Date:

Ribasphere is a nucleoside analogue indicated for the treatment of chronic hepatitis C (CHC) virus infection in combination with peginterferon alfa-2a in patients 5 years of age and older with compensated liver disease not previously treated with interferon alpha, and in adult CHC patients…

Document Date:

Ribavirin is a nucleoside analogue indicated for the treatment of chronic hepatitis C (CHC) virus infection in combination with peginterferon alfa-2a in patients 5 years of age and older with compensated liver disease not previously treated with interferon alpha, and in adult CHC patients…

Document Date:

Document Date:

Document Date:

Rifampin is indicated in the treatment of all forms of tuberculosis.

Document Date:

Document Date:

The following side effects have been associated with the use of rifapentine:

Document Date: